Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2012

Aug 3, 2012

33819_dirs_2012-08-03_a24a5c0b-4f97-40cf-a719-e01388cfcf19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-08-02

Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-02 Common Stock F 16159 $1.70 Disposed 523154 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12703 Indirect

Footnotes

F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.

F2: Includes (1) 406,000 restricted stock units, with 153,333 of this grant vesting on each of January 27, 2013, January 27, 2014 and January 27, 2015, (2) 40,000 restricted stock units vesting on June 25, 2013, and (3) 5,867 restricted stock units vesting on May 15, 2013.

F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.